# DESCRIPTION

## STATEMENT OF FEDERALLY FUNDED RESEARCH

- disclose government funding

## TECHNICAL FIELD OF THE INVENTION

- introduce DNA aptamers

## BACKGROUND OF THE INVENTION

- introduce single stranded DNA aptamers
- describe therapeutic and diagnostic applications
- summarize U.S. Patent Application No. 20080261225
- summarize U.S. Pat. No. 6,867,289
- summarize U.S. Pat. No. 7,309,786

## SUMMARY OF THE INVENTION

- introduce single stranded DNA aptamers
- describe binding to NFkB RelA
- describe quantification of RelA
- describe in vitro and in vivo applications
- introduce SEQ ID NO: 9
- describe homology to SEQ ID NO: 21
- describe in vitro and in vivo quantification
- describe isolation and purification of RelA
- describe analytical method for RelA
- introduce method for quantification of RelA
- describe binding of RelA to oligonucleotide sequences
- describe releasing bound RelA
- describe assaying released RelA
- introduce method for improving SRM-MS analysis
- describe binding of RelA to oligonucleotide sequences
- describe releasing bound RelA
- describe assaying released RelA
- introduce method for enriching RelA
- describe adding biotin conjugated oligonucleotide sequences
- describe capturing bound RelA
- describe releasing bound RelA
- introduce method for modulating innate immune response
- describe administering composition
- describe inhibiting NFkB mediated gene expression

## DETAILED DESCRIPTION OF THE INVENTION

- introduce invention
- define terms
- describe ssDNA aptamer P028F4
- describe application of P028F4 in enrichment-mass spectrometric quantification assay
- describe binding of P028F4 to activated RelA
- describe reduction of TNFα-stimulated endogenous NF-κB dependent gene expression
- describe incorporation of P028F4 as an affinity isolation step
- describe development of stable isotope dilution (SID)-SRM-MS assay
- describe quantification of activated endogenous RelA
- describe aptamer-SID-SRM-MS assay
- introduce innate immune response (IIR)
- describe nuclear factor-κB (NF-κB)
- describe regulation of NF-κB by stimulus-induced protein interactions
- describe inactivation of NF-κB/RelA by IκB inhibitory proteins
- describe activation of NF-κB/RelA by ligand-bound cell surface cytokine- or pattern recognition receptors
- describe phosphorylation of RelA at Ser residue 536- or 276
- describe binding of RelA to p300 coactivator
- describe development of tandem affinity purification (TAP) technique
- describe identification of interactome of NF-κB pathway regulators
- describe methods for selectively isolating activated NF-κB/RelA complexes
- describe aptamer selection
- describe materials used
- describe recombinant protein expression
- describe aptamer binding studies
- describe cell culture and preparation of cellular extracts
- describe whole cell extracts preparation
- describe confocal microscopy
- describe western blot
- describe electrophoretic mobility shift assays
- describe quantitative reverse transcriptase PCR
- describe two-step chromatin immunoprecipitation assay
- describe aptamer-tandem affinity purification of RelA
- describe selective reaction monitoring assays
- describe trypsin digestion of subcellular protein extracts
- describe SIS peptide stocks preparation
- describe quantification of activated fraction of endogenous RelA
- describe on-beads trypic digestion
- describe LC-SRM-MS analysis
- describe SRM data analysis
- describe isolation of RelA(1-313) binding single stranded aptamer
- describe aptamer screening and enrichment
- describe aptamer binding studies
- describe competition studies
- describe direct binding studies
- describe secondary structure analysis
- describe competition studies with natural double-strand binding sites
- describe SPR measurement of aptamer binding affinity
- describe aptamer binding to RelA and competition with duplex dsNF-κB sequences
- describe competition-EMSA study
- describe native gel electrophoresis of DNA-protein complexes
- describe NF-κB complex binding specificity
- introduce aptamer P028F4 binding to NFkB/RelA
- aptamer P028F4 competes with dsNF-κB for RelA binding
- aptamer P028F4 colocalizes with activated nuclear RelA
- aptamer P028F4 inhibits TNFα-induced NF-κB dependent gene expression
- aptamer P028F4 blocks RelA association with endogenous NF-κB dependent gene promoters
- aptamer P028F4 binds free RelA, not IκBα-associated RelA
- aptamer-TAP purification enriches for IκBα-free RelA complexes
- aptamer-TAP purification captures activated RelA complexes
- aptamer-TAP purification captures post-translationally modified RelA isoforms
- aptamer-TAP purification captures p300 complexes
- aptamer-TAP purification excludes IκBα complexes
- develop quantitative measurements for P028F4-enriched RelA and its complexes
- select and optimize SRM Q1/Q3 transitions
- optimize collision energy for SRM assays
- establish specificity of SRM quantification
- evaluate selectivity of SRM assays
- ensure peak assignment certainty
- quantify RelA using SRM assays
- determine linear response and limit of SRM quantification
- determine lower limit of quantification of SRM assay
- aptamer enrichment increases signal-to-noise ratio for RelA quantification
- combine single-step aptamer-enrichment with multiplex SRM assay
- determine aptamer capture on SA-magnetic beads is non-saturating
- quantify RelA in cells using aptamer enrichment and SRM-MS
- quantify activated RelA complex in cells
- quantify total RelA in cells
- determine fraction of activated RelA complex in cells
- describe other aptamers that bind to NFκB/RelA
- describe NF-κB pathway regulation
- describe IKK activation and IκBα regulation
- describe RelA association with p300 histone acetyltransferase
- describe nuclear-cytoplasmic oscillation of RelA
- describe utility of P028F4 for single step enrichment and quantification
- describe determination of fraction of activated RelA in unstimulated cells
- describe estimation of activated RelA molecules
- summarize aptamer P028F4 binding to RelA
- summarize aptamer P028F4 enrichment of activated RelA complexes
- summarize utility of P028F4 for quantitative SID-SRM-MS assays
- describe aptamer competition studies
- motivate genetic selection of protein-binding aptamers
- describe previous efforts isolating RelA ligands
- summarize properties of P028F4
- describe crystallographic structure of RelA-complexed to its duplex binding sites
- summarize binding characterization of P028F4
- explore properties of P028F4 as antagonist of RelA transcriptional activity
- describe non-specific aptamer effect on TNFα-inducible transcription
- describe ChIP studies
- summarize nonspecific P028A1 effects
- describe IκBα-complexed RelA interaction with P028F4
- describe binding of P028F4 to post-translationally modified RelA
- describe binding enrichment of RelA in affinity isolations
- summarize previous work on IκBα·RelA complex
- describe application of DNA aptamers in protein quantification
- summarize advantages of aptamer-based enrichment approach
- describe quantification of activated RelA molecules
- summarize theoretical understanding of NF-κB regulation
- describe dynamics of negative feedback loops
- summarize previous study on RelA cytoplasmic reservoir
- describe aptamer-SID-SRM estimation of RelA molecules
- summarize findings on activated RelA in NE and CE
- describe potential applications of NF-κB/RelA aptamers in imaging
- summarize conjugation of NF-κB/RelA aptamers to contrast agents
- describe potential diseases for imaging using NF-κB/RelA conjugated to contrast agents
- summarize potential therapeutic applications of NF-κB/RelA targeted aptamers
- describe encapsulation in nanoparticles to enhance cellular uptake
- summarize conjugation of aptamer to anti-proliferative agents
- describe effector molecules attached to aptamers for therapeutic purposes
- summarize conclusion on RelA aptamer-SID-SRM
- describe scope of the invention
- summarize disclaimer on particular embodiments

